We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus / G. Curigliano, S. Banerjee, A. Cervantes, M.C. Garassino, P. Garrido, N. Girard, J. Haanen, K. Jordan, F. Lordick, J.P. Machiels, O. Michielin, S. Peters, J. Tabernero, J.Y. Douillard, G. Pentheroudakis, A. Addeo, L. Albiges, P.A. Ascierto, F. Barlesi, C. Caldas, F. Cardoso, I.F. Chaberny, N.I. Cherny, T.K. Choueiri, M.L.K. Chua, C. Criscitiello, E. de Azambuja, D. De Ruysscher, E. de Vries, R. Dent, D. D'Ugo, R. Dziadziuszko, C. Faivre-Finn, E. Felip, M. Garassino, R. Glynne-Jones, V. Golfinopoulos, E. Hamilton, P.A. Janne, R. Kanesvaran, S.B. Kim, U.G. Liebert, T.S.K. Mok, G. Morgan, R. Obermannova, K. Park, A. Passaro, M. Reck, R. Salazar Soler, F. Scotte, S. Senan, C. Sessa, E. Smyth, R. Soo, J.C. Soria, J. Spicer, F. Strasser, D.S.W. Tan, D. Trapani, E. Van Cutsem, H. van Halteren, P.E. van Schil, G. Veronesi, J. Yang. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 31:10(2020 Oct), pp. 1320-1335. [10.1016/j.annonc.2020.07.010]

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

G. Curigliano
Conceptualization
;
C. Criscitiello;D. Trapani;G. Veronesi;
2020

Abstract

We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
COVID-19; Coronavirus Infections; Disease Management; Europe; Granulocyte Colony-Stimulating Factor; Humans; Medical Oncology; Neoplasms; Pandemics; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Societies, Medical; T-Lymphocytes, Cytotoxic; Telemedicine; Betacoronavirus; Consensus
Settore MED/06 - Oncologia Medica
Article (author)
File in questo prodotto:
File Dimensione Formato  
Curigliano and Annals COVID Consensus Delphi 2020.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 352.55 kB
Formato Adobe PDF
352.55 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/824808
Citazioni
  • ???jsp.display-item.citation.pmc??? 100
  • Scopus 158
  • ???jsp.display-item.citation.isi??? 153
social impact